Skip to main content

Herbert Irving Comprehensive Cancer Center

The Herbert Irving Comprehensive Cancer Center (HICCC) at Columbia University Medical Center was founded in 1911 as the Institute for Cancer Research. In 1972, it became an NCI-designated cancer center, and it was awarded comprehensive status in 1979. The HICCC is the University’s organizational component for the conduct of basic, clinical, and population-based cancer research and patient care.

The Center’s mission is to understand the biology of cancer and apply that knowledge to the design of cancer therapies and prevention strategies that reduce its incidence and progression. HICCC’s more than 240 members are drawn from six schools at Columbia and, joined with the cancer-related patient services provided at New York Presbyterian Hospital, form an extensive collaborative group of researchers and clinicians working to provide the best approaches for prevention, diagnosis, and treatment of all types of cancer.

Research at HICCC is organized into eight research programs within three divisions. The Basic Science Division includes programs in Cancer Regulatory Networks and Cancer Genetics and Epigenetics. Programs in the Disease-Specific Division focus on Breast Cancer, Lymphoid Development and Malignancy, Prostate Cancer, and Neuro-Oncology. The Population Science Division’s programs include Cancer Epidemiology as well as Prevention, Control, and Disparities. These programs focus on different aspects of cancer from its molecular and cellular mechanisms through its unique behavior in different tissues to statistical aspects of its occurrence and treatment in large populations. The members of each program share a commitment to reduce cancer incidence and tumor progression and to improve the quality of life of those affected by cancer.

 

College of Physicians & Surgeons Columbia University

Comp
Anil Rustgi, MD
Director
1130 St. Nicholas Avenue
Room 508
New York, NY 10032
(212) 851-4764
Admin Leader
Emer Smyth, PhD
Director, Cancer Research Alliances
COE Leader
Mary Beth Terry, PhD
Associate Director for Population Science and Community Outreach
CRTEC Leader
Wendy Chung, MD, PhD
Associate Director for Education and Training
PED Leader
Sandra Ryeom, PhD
Associate Director for Diversity, Equity and Inclusion

Research Programs

Research Program Program Leaders
Cancer Genomics and Epigenomics Jean Gautier, PhD; Raul Rabadan, PhD; Susan Bates, MD
Cancer Population Science Dawn Hershman, MD, MS; Mary Beth Terry, PhD; Chin Hur, MD, MPH
Precision Oncology and Systems Biology Andrea Califano, Dr; Kenneth Olive, PhD; Gulam Manji, MD, PhD
Tumor Biology and Microenvironment Michael Shen, PhD; Timothy Wang, MD; Barbara Pro, MD

Shared Resources

Category Resource Directors
Cat 1: Laboratory Science Biomarkers Regina Santella, PhD; Hui-Chen Wu, PhD
Cat 1: Laboratory Science Confocal and Specialized Microscopy Liza Pon, PhD
Cat 1: Laboratory Science Flow Cytometry Remi Creusot, PhD
Cat 1: Laboratory Science Genetically Modified Mouse Models Jianwen Que, MD, PhD
Cat 1: Laboratory Science Genomics and High Throughput Screening Olivier Couronne, PhD; Charles Karan, PhD; Peter Sims, PhD; Aris Floratos, PhD
Cat 1: Laboratory Science Oncology Precision Therapeutics and Imaging Core Kenneth Olive, PhD
Cat 1: Laboratory Science Proteomics and Macromolecular Crystallography Brent Stockwell, PhD
Cat 3: Epidemiology, Cancer Control Database Jeanine Genkinger, PhD
Cat 4: Clinical Research Molecular Pathology Hanina Hibshoosh, MD
Cat 6: Biostatistics Cancer Biostatistics Jianhua Hu, PhD
Last Updated
June 5, 2024